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Uterine contractions are involved in preterm labour (PTL) and dysmenorrhoea. Preterm labour, 
which leads to preterm births (PTBs), is a major cause of perinatal mortality and morbidity 
(Goldenberg 2002; Goldenberg et al. 2008). Premature infants are highly susceptible to potentially 
life-threatening complications, which include, but are not limited to, jaundice, hypoglycaemia, 
hypothermia, infection and respiratory distress syndrome (Steer & Flint 1999). Although some 
improvements in neonatal survival rates because of improved neonatal care have been observed 
in recent years, the incidence of PTB itself has seen little improvements (Bocking 1998). Preterm 
birth originates from premature uterine contractions and is still one of the major obstetrical 
problems (Maltaris et al. 2006). Several drugs have been used as tocolytics and they include 
ȕ-adrenoceptor mimetics, calcium antagonists, prostaglandin (PG) inhibitors and alcohol (Keirse 
2003). Tocolysis (pharmacological inhibition of uterine contractility) aids in counteracting PTL 
and postponing delivery and is still the current mainstay of PTL management. Use of tocolytics is 
an important intervention as it enables delivery to be delayed long enough for transfer of the 
mother to a specialist tertiary centre or for corticosteroids to be administered to the mother which 
promotes maturation of foetal lung (Goldenberg 2002). However, the wide range of tocolytics in 
Background: The leaves of Alchornea laxiflora are traditionally used in the south of Nigeria to 
prevent preterm births.
Aim: This study was designed to investigate the activity of A. laxiflora on uterine contractility.
Setting: The leaves of the plant were collected from forests in Egor, Benin City, Nigeria.
Methods: The leaves were cleaned and extracted in methanol. The extract (0.005 mg/mL–
3.5 mg/mL) was tested on spontaneous uterine contraction and on oxytocin-induced 
contraction in normal and Ca2+-free media. The plant extract (0.0035 mg/mL, 0.035 mg/mL, 
0.35 mg/mL and 3.5 mg/mL) was tested on high KCl-induced uterine contractions 
(80 mM). The plant extract (3.5 mg/mL) was also studied in the presence of amiodarone 
and glibenclamide in separate experiments. Mass spectrometric analysis was additionally 
performed on the plant extract in order to identify significant secondary metabolites that 
may have contributed to the activity of the plant.
Results: The plant extract inhibited spontaneous, oxytocin and high KCl-induced uterine 
contractions and also significantly inhibited (p < 0.01) oxytocin-induced uterine contraction in 
Ca2+-free medium. The plant extract significantly inhibited (p < 0.01 and p < 0.05) oxytocin’s 
amplitude in the presence of amiodarone and glibenclamide, respectively. Secondary 
metabolites belonging to classes of fatty acids, glycols, terpenes, flavonoid glycosides and 
porphyrins were identified.
Conclusion: Alchornea laxiflora inhibited mouse uterine contractility possibly through 
interaction with potassium and calcium channels. Of the known metabolites identified, 
3-deoxy-arabino-hept-2-ulosonic acid, 17-hydroxyingenol and phaeophorbide-a methyl 
inhibit uterine contractility and may contribute to the activity of A. laxiflora in utero.
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use suggests that an ideal drug is yet unavailable (Keirse 
2003). The most frequently-used tocolytic drugs today are the 
ȕ-adrenoceptor mimetics, which are known to have a number 
of adverse effects (Berkman et al. 2003). This, therefore, calls 
for the exploration of indigenous medicinal plants that could 
potentially lead to the discovery of new potent drug 
compounds with little or no adverse effects. Dysmenorrhea, 
on the other hand, is considered the most common 
gynaecological condition among women within the 
reproductive age and can be defined as painful menstrual 
cramps originating from the uterus, which remains under-
diagnosed and under-treated (Campbell & McGrath 1997; 
Coco 1999; Proctor et al. 2010). The pain experienced by 
women with dysmenorrhea can be significantly incapacitating 
and has been described as similar to renal colic pain (Ayan 
et al. 2012). The prevalence of dysmenorrhea is high and 
its consequences are extensive. Dysmenorrhoea has been 
reported to have a negative impact on different aspects of the 
personal lives of those affected, and this includes school or 
work performance, family relationships, and social and 
recreational activities (Eryilmaz, Ozdemir & Pasinlioglu 
2010; Ortiz 2010; Wong & Khoo 2010). This is probably 
because the intense cyclic pain restricts physical activity 
(Chen et al. 2006; Dawood 1995; Zuliani et al. 2009). It has 
been reported that women with dysmenorrhoea have high 
levels of PGs, which are hormones that can mediate uterine 
contractility, causing cramping abdominal pain (Marjoribanks 
et al. 2010). Prostaglandins are allegedly released from 
disintegrating cells during endometrial sloughing, which 
results in myometrial hypercontractility that then leads to 
ischaemia and hypoxia of the uterine muscle and, ultimately, 
pain (Dawood 1988). The most common treatment for 
primary dysmenorrhea (PD) (which is dysmenorrhoea 
with no known pathology) includes non-steroidal anti-
inflammatory drugs (NSAIDs) that combat menstrual pain 
by reducing intrauterine pressure and inhibiting the enzyme 
necessary for synthesis of prostaglandin F2 alpha (PGF2Į), 
leading to reduced levels in menstrual fluid. However, a 
reasonable percentage (about 15%) of women who suffer 
from dysmenorrhea have been reported to respond poorly or 
are intolerant to PG inhibitors (Campbell & McGrath 1997). 
The failure rate of NSAIDs falls between 20% and 25% 
(Dawood 1995), and is often contraindicated in some women 
(Taylor, Miaskowski & Kohn 2002). Non-steroidal anti-
inflammatory drugs have long-term adverse effects which 
include disorders of the liver, kidney and digestive systems 
(Liu et al. 2011). Many women have therefore resorted to 
alternative therapies including non-pharmacologic therapies 
in order to manage their menstrual discomfort (Campbell & 
McGrath 1997; Ogunfowokan & Babatunde 2010; Ou et al. 
2012). Oral contraceptives (OCPs) have also been used to 
manage dysmenorrhoea by suppressing ovulation and 
causing a thinned endometrial lining that results in reduced 
menstrual fluid volume, reduced amount of PG produced 
and consequently reduction of uterine contractions and 
therefore pain (Creatsas et al. 1990). However, OCPs can 
cause side effects, including nausea and water retention, and 
are contraindicated in women who intend to get pregnant 
(Hendrix & Alex 2002). Surgical interruption of the pelvic 
nerve pathways has also been used in women, but the long-
term efficacy of this method lacks evidence and it is not 
a commonly-accepted procedure (Proctor et al. 2010). The 
limitations associated with these conventional treatments 
have made herbal medicines feasible alternatives for the 
treatment of PD (Park et al. 2014). Many patients who 
failed to respond to conventional PD treatments have been 
treated with herbal medicines (Chen et al. 2006; Proctor & 
Murphy 2001).
Medicinal plants have been a valuable source of therapeutic 
agents, and still many of today’s drugs are plant-derived 
natural products or their derivatives (Kinghorn et al. 2011; 
Newman & Cragg 2012). Traditional cultures worldwide 
depend on herbal remedies for different conditions in 
menstrual disorders, pregnancy, birth and post-partum 
care. This, therefore, makes scientific investigation and 
documentation of traditional knowledge of medicinal plants 
a crucial event, which assists chemists and pharmacologists 
with starting points for ‘targeted’ analysis, discovery of novel 
therapies and natural drugs for the treatment of pregnancy 
and uterine-related issues (Gruber & O’Brien 2011). For 
drug discovery targeting dysfunctional labours, medicinal 
plants with oxytocic or uterine stimulating activities are 
of significant interest, while for PTLs, those with uterine 
relaxing activities are sought. Similarly, use of herbal 
medicines in dysmenorrhoea has received some attention 
(Mirabi et al. 2014; Van Andel et al. 2014), which signifies the 
importance in the search for new remedies from medicinal 
plants. The tropical plant, Alchornea laxiflora (AL) (Benth) Pax 
and Hoffman, of the Euphorbiaceae family, is one of such 
medicinal plants used by traditional healers in the south of 
Nigeria for managing uterine contractility, particularly in the 
prevention of miscarriages (personal communication with 
traditional healer Mr Eyohan). It is called Uwenriotan by Edo 
natives, Ububo in the Igbo language and Ijan or Opoto in the 
Yoruba language, Nigeria. It is a broad-leafed shrub that 
sheds its leaves annually and grows to a height of about 
6 m–10 m. It can be found abundantly in Nigeria, Cameroon, 
in DR Congo, throughout East Africa and in Zimbabwe 
(Burkill 1994). The stems, especially the branches, are used in 
Nigeria as chew-sticks and the leaves are used to preserve 
cola nut in Nigeria. Other traditional use includes the 
management of piles, dysentery, malaria, eczema, cough and 
high fever (Jayeoba, Ijeomah & Ogara 2012). The decoctions 
of the leaves of AL have been reported to have antimicrobial 
effects (Oloyede et al. 2010), antioxidant activity (Farombi et 
al. 2003), hepatoprotective effects (Oloyede et al. 2011) and 
have been shown to exert a progesterone-like effect (Bafor et 
al. 2016). For PTL prevention, the leaves of AL are collected 
fresh, preferably at dawn and dusk, washed and squeezed 
into a glass full of water. The mixture is then filtered and 
mixed with ‘calabash chalk’ or ‘calabash clay’, often referred 
to as ‘eko’ in Nigeria, and the concoction is taken twice daily 
(morning and evening) after conception for a period of 
six months (personal communication with traditional healer 
Mr Eyohan). In the search for potential targets for new 
therapies in managing PTL and dysmenorrhoea, this study 
was aimed at investigating the activity of the plant AL on 
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uterine contractility and to additionally investigate possible 
mechanisms of action. This study is also aimed at identifying 
significant secondary metabolites present in the plant that 
may have contributed to the plant’s biological activities.
Materials and method
Plant material
Fresh leaves of AL were collected from Egor, 6.3350°N 
5.6038°E Benin City in Edo state, Nigeria, in April 2015, with 
an average humidity of 75% and an average temperature 
of 35°C. Identification was done by Dr H.A. Akinnibosun 
of the Department of Plant Biology and Biotechnology, 
University of Benin, Nigeria, and authenticated by Prof. B.A. 
Ayinde of the Department of Pharmacognosy, University of 
Benin, Nigeria. A voucher specimen number of UBHe0286 
was provided.
Animals
Mature non-pregnant female albino mice weighing an 
average of 25 g ± 0.57 g, aged 4–5 months, were obtained 
from the animal house, Department of Pharmacology and 
Toxicology, Faculty of Pharmacy, University of Benin, 
Edo state, Nigeria. The animals were housed in plastic cages 
at an environmentally controlled room temperature of 
approximately 27°C ± 5°C and lighting conditions of 
approximately 11 or 13 h light and dark cycles. Relative 
humidity ranged from 80% to 85%. The animals were 
handled as much as possible according to the standards 
of the Public Health Service Policy on Humane Care and 
Use of Laboratory Animals (National Research Council 
2010; NIH 2015). The animals were maintained on a standard 
diet of animal pellets and clean tap water.
Drugs and chemicals
Methanol (MeOH) of high analytical grade (Pharmatrends, 
Nigeria) and Tween 80 (Sigma Aldrich, Dorset, UK) 
were solvents used in this study. Salts for the physiological 
solution were obtained from BDH Chemicals, England. Other 
drugs used in the study include oxytocin (OT) (Laborate 
Pharmaceuticals, Haryana, India), amiodarone (AM) and 
glibenclamide (GLB) (Sigma Aldrich) and diethylstilboesterol 
(Sigma Aldrich). For the mass spectrometric experiments, 
MeOH, dichloromethane (DCM), acetonitrile (MeCN) and 
formic acid were purchased (Fisher Scientific, Hemel 
Hempstead, UK). All reagents were of analytical grade.
ǆƚƌĂĐƟŽŶŽĨƚŚĞƉůĂŶƚŵĂƚĞƌŝĂů
The collected leaves were cleaned and freed of debris 
before being shade-dried for two weeks. The dried leaves 
were then grounded using a milling machine (Christy 
Norris, England). The powdered samples were kept in 
airtight containers and stored in the refrigerator at 4°C. 
The powdered material (855.24 g) was subsequently 
extracted in MeOH using a Soxhlet apparatus. Exhaustive 
extraction was performed for 48 h and the resulting 
solution was filtered and concentrated in a rotary 
evaporator set at 40°C. The concentrate obtained was dried 
in an oven at 40°C and the extract weight was determined 
to be 122.3 g (percentage yield was 14.3% w/w). The extract 
was then stored in airtight containers and kept in the 
refrigerator (~4°C) till needed.
ŽŶƚƌĂĐƟůŝƚǇƐƚƵĚŝĞƐ
hƚĞƌŝŶĞƟƐƐƵĞƉƌĞƉĂƌĂƟŽŶ
Each mouse (four animals per protocol) was administered 
1.0 mg/kg diethylstilboesterol (DES) orally constituted in 
Tween 80 and distilled water (1:1), 24 h prior to the day of 
experiments. Oral administration was done using a feeding 
syringe. Dose and route of DES administration had been 
previously determined in our laboratory to effectively induce 
oestrus. On the day of the experiment, vaginal smears were 
obtained and prepared as previously described (Caligioni 
2009; Cora, Kooistra & Travlos 2015). Briefly, with the aid of a 
Pasteur pipette (0.1 mm), the vaginal smears were collected, 
fixed with ethanol and stained with a drop of Gentian violet. 
The smears were then observed under a microscope using a 
×10 objective lens in order to ascertain the oestrus stage 
animals in pro-oestrus and oestrus stages were selected and 
humanely killed by cervical dislocation and the uterine horns 
were immediately excised and placed into a Petri dish 
containing previously warmed and aerated physiological 
salt solution. The uterine tissues were cleaned of connective 
tissues and one horn was dissected into half to obtain a 
segment of the uterine horn. Tissue lengths of approximately 
1 mm–2 mm each were obtained. The uterine segment was 
then mounted in a warmed 10 mL organ bath maintained at 
37°C and containing aerated physiological solution. The 
physiological salt solution used was of the following 
composition in M: NaCl 154.00, NaHCO3 5.95, D-glucose 
2.78, KCl 5.63 and CaCl2·2H2O 2.05 (Bafor, Obarisiagbon & 
Itamaomon 2015).
Experimental protocol
The uterine tissues were mounted in organ baths and 
equilibrated under resting tensions of 4.90 mN for 30–45 min 
or until regular contractions were obtained (time duration 
used was dependent on when regular contractions were 
obtained) (Sukwan, Wray & Kupittayanant 2014). The force 
and frequency of uterine contractions in the longitudinal 
muscle layers were measured using a 7003E-isometric force 
transducer (Ugo Basile, Varise, Italy) connected to a 17 400 




The cumulative effect of the extract on uterine smooth 
muscle contractility was investigated (Bafor et al. 2013). 
Concentration–response relationships were obtained at 
0.005 mg/mL–3.5 mg/mL. The concentration used had 
been predetermined in our laboratory as concentrations 
covering the range of effects of the extract. A contact time 
of 3 min was allowed following each concentration of 
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extract administered. After each set of administration, the 
tissues were washed three times and a washout period 
minimum of 10 min was allowed for the tissue to recover 
before the next administration (Bafor et al. 2017).
ǆƉĞƌŝŵĞŶƚŽŶƚŚĞĞīĞĐƚŽĨĞǆƚƌĂĐƚŽŶŽǆǇƚŽĐŝŶ ?ŝŶĚƵĐĞĚ
ƵƚĞƌŝŶĞĐŽŶƚƌĂĐƟŽŶ
The effect of the extract on OT-induced uterine contraction 
was investigated. This was done by first performing a 
concentration response to OT (0.00017 ng/mL–4.98 ng/mL) 
in the absence of the extract, which was then repeated in 
the presence of cumulative sub-maximum concentrations 
of the extract at 0.35 mg/mL and 3.5 mg/mL at 5 min each. 
Conversion of OT from international units (IUs) to milligram 
was in accordance with the World Health Organization 




The activity of the extract on high KCl-induced (80 mM) tonic 
uterine contracture was investigated. KCl (80 mM) was 
added to the bath containing the uterine tissues and left in 
contact with the tissue for 5 min, and without washing, 
cumulative concentrations of the extract (0.0035 mg/mL–
3.5 mg/mL) were determined.
ǆƉĞƌŝŵĞŶƚŽŶƚŚĞĞīĞĐƚŽĨƚŚĞĞǆƚƌĂĐƚŝŶĂ2+ ?ĨƌĞĞ
medium
After tissue equilibration for 30 min, the physiological salt 
solution was changed to one without calcium and containing 
0.1 mM of ethylenediaminetetraacetic acid (EDTA). The 
tissue was then equilibrated in the Ca2+-free solution for a 
further 15 min. After equilibration, OT (0.05 mM) was added 
and a contact time of 5 min was allowed. Without flushing, 
the extract (3.5 mg/mL) was added. A contact time of 5 min 
was allowed for the extract concentration.
ǆƉĞƌŝŵĞŶƚŽŶŝŶƚĞƌĂĐƟŽŶŽĨĞǆƚƌĂĐƚǁŝƚŚ<+ ?ĐŚĂŶŶĞůƐ
The effect of the extract (3.5 mg/mL) on OT-induced 
contraction (0.05 mM) was determined in the absence and 
presence of AM (0.04 mM) and GLB (0.04 mM) – both 
adenosine triphosphate (ATP)-sensitive K+-channel blocker. 
This was achieved by addition of OT to the tissue bath and 
this was left in contact for 5 min and without flushing, the 
extract was added and left for a further 5 min. Without 
washing, AM or GLB was then added to the bath and the 




Samples were prepared at a concentration of 1 mg/mL 
in 80:20 MeOH:DCM. A solvent blank was also included. 
Liquid chromatography–high-resolution Fourier Transform 
mass spectrometry (LC-HRFTMS) analysis was performed 
on a Dionex UltiMate-3000 (DIONEX, Sunnyvale, CA, USA) 
coupled to a Thermo Scientific Exactive Orbitrap system 
(Thermo Fisher Scientific (Bremen) GmbH, Bremen, Germany). 
The mass accuracy was set to less than 3.0 ppm. The instrument 
was externally calibrated according to the manufacturer’s 
instructions before the run. An ACE C18 column with 
dimensions of 75 × 3.0 mm from Hichrom Ltd., Reading, UK, 
was used. Parameters used were as previously described 
(Bafor et al. 2016). Briefly, 10 µL of the sample was injected from 
the vial and elution flow rate was set at 300 µL/min with water 
(A) and MeCN (B), both of which contained 0.1% formic acid. 
A gradient flow was used, starting with 10% B and increasing 
to 100% B in 30 min. The mobile phase was maintained for 5 
min at 100% B; this was followed by equilibration of the column 
with 10% B. The resulting data files were divided into positive 
and negative data sets using ProteoWizard (Kessner et al. 2008) 
prior to data mining that was performed with the use of 
MZmine 2.10 (Pluskal et al. 2010). Peak detection was 
accomplished using the centroid mass detector and a noise 
level of 1000 was set. The chromatogram builder generated 
peak lists from the mass lists obtained from the previous step. 
The minimum time span was 0.2 min, the minimum height 
was 10 000 intensity and the m/z tolerance was set at 0.0001 
m/z or 5 ppm. Chromatogram deconvolution was accomplished 
using the local minimum search algorithm with the following 
parameters: threshold (90%), search minimum in retention 
time (RT) range (0.4 min), minimum relative height (5%), 
minimum absolute height (10 000 intensity), minimum ratio of 
peak top or edge (Goldenberg 2002) and peak duration range 
(0.2–5.0 min). The peak lists were de-isotoped using the isotopic 
peaks grouper with an m/z tolerance of 0.001 m/z or 5 ppm, RT 
tolerance of 0.1 min (absolute) and maximum charge of 2. The 
representative isotope was the most intense. The peak lists 
were then merged using the alignment function. The weight 
for m/z and for RT was 20, and the RT tolerance was 5%. The 
aligned peak lists were gap-filled using the PeakFinder, with 
an intensity tolerance of 1% and RT tolerance of 0.5 min 
(absolute) (Macintyre et al. 2014). The adducts were identified 
together with other complexes that may have formed within 
the metabolite pool. The chemical formulae of each peak were 
predicted using the formula prediction tool developed by 
MZmine. ChemBioFinder version 13 (PerkinElmer Informatics, 
Cambridge, UK) was used to access hits from the database.
ĂƚĂĂŶĂůǇƐŝƐ
The mean frequency and amplitude were computed from 
contractions occurring at the last 3 min of the phasic 
contractions using the GraphPad Prism (version 7.03; 
GraphPad Software Inc, San Diego, CA, USA). Results were 
obtained as percentages of control applications (control = 
100%) where necessary and changes in force (amplitude) or 
frequency were expressed with respect to control (100%). All 
data shown were expressed as mean ± standard error of 
mean (SEM) and n represents the number of animals (in this 
study, n = 4 animals). Significance was evaluated using 
appropriate t-tests, and where necessary, one-way analysis of 
variance with Dunnett’s post hoc test and p values  0.05 was 
taken to represent the minimum significance in all cases.
In data sets with sufficient data points, mean log concentration–
response curves were analysed by fitting data to a variable slope 
WĂŐĞ ?ŽĨ ? ? KƌŝŐŝŶĂůZĞƐĞĂƌĐŚ
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logistic equation, using the following equation values: Y = 
Bottom + (Top-Bottom)/(1 + 10^((LogIC50-X)*HillSlope)), 
where Y is the response that starts at the bottom and goes to the 
top in sigmoid shape, X is the logarithm of concentration and 
half maximal inhibitory concentration (IC50) is the concentration 
that gives a response half way between bottom and top.
ƚŚŝĐĂůĐŽŶƐŝĚĞƌĂƟŽŶƐ
Ethical permission was obtained prior to start of the 
experiments from the Faculty of Pharmacy Animal Ethics 
Committee, University of Benin, Nigeria, and the study was 
provided an approval reference number: EC/FP/016/08.
Results
sĂŐŝŶĂůĐǇƚŽůŽŐǇŽĨƚŚĞĞǆƉĞƌŝŵĞŶƚĂůĂŶŝŵĂůƐ
Representative exfoliative vaginal cytology for the stage of 
the oestrus cycle of animals utilised for this study is presented 
in Figure 1. The relative prevalence of the cell type was used 
to ascertain the oestrus phase for each recipient mouse. 
Typically, animals in the oestrus and pro-oestrus phases were 
utilised for this study.
īĞĐƚŽĨĞǆƚƌĂĐƚŽŶƐƉŽŶƚĂŶĞŽƵƐƵƚĞƌŝŶĞ
ĐŽŶƚƌĂĐƟŽŶ
Cumulative concentration–response experiments were 
performed to determine the effects of the extracts on the 
force and frequency of spontaneous uterine contractions. 
Response curves were determined for AL (n = 5). Alchornea 
laxiflora was observed to inhibit spontaneous uterine 
contractions at higher concentrations (Figure 2). However, 
lower concentrations appeared to slightly increase 
contractility (Figure 2a). Both the amplitude and frequency 
of spontaneous uterine contractions were inhibited by AL; 
however, AL appeared to have more effect on the amplitude 
than on the frequency (Figure 2b).
īĞĐƚŽĨĞǆƚƌĂĐƚŽŶŽǆǇƚŽĐŝŶ ?ŝŶĚƵĐĞĚƵƚĞƌŝŶĞ
ĐŽŶƚƌĂĐƟŽŶƐ
Experiments were performed to characterise the activities of 
AL on OT-induced uterine contractions. Alchornea laxiflora 
was observed to inhibit OT-induced uterine contractility. 
Two concentrations of AL were used for this phase of 
the study. At the lower concentration of 0.35 mg/mL, no 
marked inhibition was observed for both amplitude and 
frequency of contraction, but a reduction of the baseline 
tension was seen (Figure 3a). However, at 3.5 mg/mL AL, 
there was a rightward shift in the amplitude and frequency 
concentration–response curves of OT (Figure 3b and c).
īĞĐƚŽĨĞǆƚƌĂĐƚŽŶŚŝŐŚƉŽƚĂƐƐŝƵŵĐŚůŽƌŝĚĞ ?
ŝŶĚƵĐĞĚƵƚĞƌŝŶĞĐŽŶƚƌĂĐƟŽŶ
Characterisation of the actions of AL to high K+ solution was 
performed. The possibility of interaction of AL with extracellular 
calcium channels involved in high K+ depolarisation of 
smooth muscles (Triggle 1987) was investigated. High KCl 
solution produced a rapid increase in force that was 
immediately preceded by a decline and rapidly oscillating 
production of force (Crichton et al. 1993). Alchornea laxiflora 
inhibited high KCl-induced contraction and this inhibition 
was more pronounced at the concentration of 3.5 mg/mL 
(Figure 4a). This was observed as a decrease in the amplitude 
of response elicited by high KCl (Figure 4b).
īĞĐƚŽĨĞǆƚƌĂĐƚŝŶĂ2+ ?ĨƌĞĞŵĞĚŝƵŵ
Further experiments were designed to investigate whether AL 
extract could inhibit internal Ca mobilisation from the 
sarcoplasmic reticulum (Arrowsmith & Wray 2014; Wray & 
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blocked by utilisation of a Ca-free medium. In a medium 
containing zero-calcium, AL (3.5 mg/mL) reduced the 
contractions of OT-induced uterine contractions (Figure 5a). 
On analysis, a significant inhibition (p < 0.01) by AL on OT-
induced contraction (0.005 mM) was observed (Figure 5). 
Alchornea laxiflora reduced the amplitude of OT-induced 






A further inhibition of OT-induced (0.05 mM) uterine 
contraction by AL (3.5 mg/mL) was observed in the presence 
of AM (0.04 mM) (Figure 6a). This was shown in the bar plots 
where analysis showed that AL significantly inhibited (p < 
0.01) OT in the presence of AM (Figure 6b). Oxytocin was 
reduced by AL to 78.70% of the original amplitude of 
contraction, which was further reduced to 59.81% in the 





This experiment was performed in order to evaluate the 
specific interactions of AL with K+ channels, ATP- sensitive 
potassium channels (K+ATP)-, and ȕ-adrenoceptors. Therefore, 
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blocker) (Zhang et al. 2016) and in the presence of GLB (K+ATP 
inhibitor) (Luzi & Pozza 1997), the inhibitory effect of AL on 
OT was evaluated. In the presence of AM, AL was observed 
to significantly inhibit (p < 0.05) OT-induced contraction 
(Figure 7). Similarly, in the presence of GLB, AL significantly 
inhibited (p < 0.05) OT-induced contraction (Figure 7). In 




Significant secondary metabolites that make up the 
major constituents of AL were identified. The LC-HRFTMS 
results and database search (using Dictionary of Natural 
Products) enabled the detection of 18 significant 
compounds (Tables 1 and 2). Seven compounds were 
known (Table 1) and 11 were unknown (Table 2). The 
identified compounds are (1) 4-Amino-4-deoxyarabinose; 
Į-D-Pyranose-form, Me glycoside, (2) 2-Methyl-1,2,3,4-
butanetetrol; (2S,3R)-form, 4-Phosphate, (3) 2-Amino-4,5-
dihydroxy-3,4-dimethylpentanoic acid; (2S,3S,4R)-form, Î³-
Lactone, (4) 3-Deoxy-arabino-hept-2-ulosonic acid, (5) 
Adipedatol, (6) 17-Hydroxyingenol; 17-Benzoyl, 3-angeloyl, 
5-Ac and (7) Phaeophorbide-a; 10-Epimer, 3″-Me ester. 
The chromatogram depicted the individual peaks of the 
identified compounds (Figure 8) and the structures of the 
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OT alone (0.05 mM)
OT + AL (3.5 mg/ml)
OT + AL + Amiodarone (0.04 nM)
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OT alone (0.05 mM)
OT + AL (3.5 mg/ml)
OT + AL + Glibenclamide (0.04 nM)
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Discussion
Alchornea laxiflora has been shown in this study to inhibit 
spontaneous and OT-induced uterine contraction of the non-
pregnant uterus. The uterus is chiefly made up of smooth 
muscle cells and is characterised by spontaneous and 
rhythmic oscillations of contractions and relaxations (Kelly 
1962; Pehlivano÷lu, Bayrak & Do÷an 2013). This uterine 
activity of myogenic origin is observed even in denervated 
preparations (Bulletti et al. 1993). In the non-pregnant uterus, 
contractions act to expel menstrual debris in the early 
follicular phase, in propelling spermatozoa from the cervix 
to the distal tube ends (de Vries et al. 1990), and assist in the 
return of oocytes or embryos to the uterine cavity. Uterine 
contractility also favours proper placement of concepti in 
the uterine cavity and is therefore important in implantation 
(Bulletti et al. 2000). Abnormal uterine contractility 
(dyskinesia) may result in pelvic pain (dysmenorrhea), 
abortion and PTL (Bulletti et al. 1993; Kelly 1962). It has been 
shown that an increase in frequency of uterine contractions 
occurs during the follicular phase followed by a decrease 
during the luteal phase of the menstrual cycle (Bulletti et al. 
1993; Lyons et al. 1991). However, the amplitude of uterine 
contractions increases during the luteal phase and is 
subsequently decreased at the time of menstruation (Bulletti 
et al. 2000). The stage of cycle used in this study was the late 
follicular and ovulation stages where frequency of uterine 
contractions is high. We observed an initial increase in 
tension that was attenuated with higher concentrations of 
the extract resulting in a decrease in amplitude and frequency 
even in conditions where frequency of contractions is 
expectedly higher than other cycle phases. Spontaneous 
contractions have been attributed primarily to the influx of 
Ca2+ (Shmigol, Eisner & Wray 1998; Wray et al. 2003) from 
the intracellular and extracellular spaces (Floyd & Wray 
2007). This therefore suggests a possible inhibition of calcium 
influx by AL. Stimulation of OT receptor by OT activates the 
phospholipase C system, which, in turn, leads to the eventual 
mobilisation of Ca2+ from intracellular stores; this is 
considered the canonical pathway for OT stimulation of 
uterine contractility (Arrowsmith & Wray 2014; Wray 2007). 
However, Ca2+ from extracellular space also contributes to 
the rise in [Ca2+]i stimulated by OT. Contribution of Ca
2+ 
from extracellular space appears to occur via voltage-
operated calcium channels (VOCCs) which are also essential 
for the phasic, spontaneous uterine contractions (Wray et al. 
2001). The inhibition of OT by AL additionally supports AL 
inhibition of Ca2+ but also proposes interaction of AL with 
the second messenger metabolites involved in OT’s activity. 
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contractions similarly suggests inhibition of a common 
signalling pathway that appears to be Ca2+ and more likely 
inhibition of Ca2+ through VOCCs, as the operation of 
VOCCs is shared in both spontaneous and OT-induced 
uterine contractions. In order to investigate this possibility 
further, the effect of AL on depolarised tissues was studied. 
This was achieved in the presence of high KCl which opens 
L-type VOCCs (Granger, Hollingsworth & Weston 1986; 
Niedergerke 1956), resulting in a sustained depolarisation of 
the tissues (Little, Teaf & Hurwitz 1985). Again, the 
depolarisation by KCl was inhibited by AL in this study, 
further supporting the interaction of AL with Ca2+. 
Importantly, Ca2+ contribution in uterine contractility 
involves the intracellular stores as well as the VOCCs. In 
order to examine the possibility of AL inhibiting the 
intracellular release of Ca2+, the activity of AL was examined 
in Ca2+-free medium. In the absence of Ca2+ in the medium, 
AL inhibited the effect of OT where Ca2+ arises principally 
from intracellular stores (Kupittayanant, Luckas & Wray 
2002; Luckas, Taggart & Wray 1999). This suggests a possible 
activity of AL on both L-type VOCCs and intracellular 
Ca2+ stores and also supports interaction with inositol 
triphosphate (IP3), a second messenger involved in OT’s 
contractility by regulating intracellular Ca2+ release (Stepien 
& Ziecik 2002; Zingg & Laporte 2003). In order to investigate 
possible involvement of K+ channels on AL’s activity, the 
extract was tested on OT’s effect in the presence of K+-
channel blockers (AM and GLB). Potassium channels exist in 
the myometrium and function to neutralise depolarisations 
and prevent generation of action potentials when necessary 
(Piedras-Renteria, Stefani & Toro 1991). Amiodarone and 
GLB have been reported to inhibit ATP-sensitive K+ channels 
(K+ATP) (Grover & Garlid 2000; Holmes et al. 2000). Opening 
of K+ATP channels in smooth muscle cells would lead to 
hyperpolarisation of the membranes and eventual relaxation 
(Grover & Garlid 2000). Therefore, blockade of K+ATP would 
prevent relaxation and potentiate depolarisation. The effect 
of AL on OT in the presence of either AM or GLB was more 
potent than when tested alone, suggesting that in addition to 
blockade of Ca2+ channels AL also activates opening of K+ 
channels in the myometrium. Earlier studies had described a 
progesterone-like effect of AL (Bafor et al. 2016). Progesterone 
promotes inhibition of the frequency of uterine contractility 
(Bulletti et al. 2000) and is also necessary for maintaining 
uterine quiescence during pregnancy (Gellersen, Fernandes 
& Brosens 2009). Progesterone is also known to inhibit Ca2+ 
channels and activate K+-channels (Soloff et al. 2011) and 
therefore supports the observed effect of AL in this study.
Mass spectrometric analysis led to the identification of seven 
secondary metabolites and others were unknown. Of those 
identified some knowledge regarding their biological activity 
and possible involvement in the activity of AL is described. 
The metabolite 4-Amino-4-deoxyarabinose is a pentosamine. 
Pentoses range from complex carbohydrates such as the 
antibiotic everninomicin to simple sugars such as L-arabinose 
and L-xylose. Several biological activities of pentose 
compounds have been reported, ranging from antimicrobial 
to anticancer activities (Forsman & Leino 2011). With regard to 
their involvement with organs of the reproductive system, not 
much is known; however, sugars have been reported to 
regulate some ligand function and sperm motility in mice 
(Chapman & Barratt 1996). The metabolite 2-methyl-1,2,3,4-
butanetetrol, also known as 2-methylerythritol, is a soluble 
carbohydrate that is found in certain higher plants and is 
likely a dephosphorylated form of 2-C-methyl-D-erythritol-4-
phosphate (MEP). The form MEP is a central component 
to the non-mevalonate pathway for isoprenoid synthesis 
(Witczak, Whistler & Daniel 1984). As far as contribution to 
uterine signalling is concerned, no specific relationship has 
been observed so far. The metabolite 2-amino-4,5-dihydroxy-
3,4-dimethylpentanoic acid is an amine acid. Amine acids 
primarily function as components of proteins and some are 
considered as essential compounds that must be ingested as 
they partake and support bodily functions including pain 
relief (Wu 2009). The exact biological role of 2-amino-4,5-
dihydroxy-3,4-dimethylpentanoic acid in uterine function is, 
however, unknown at this time. The compound 3-deoxy-
arabino-hept-2-ulosonic acid is a keto ester (Liu et al. 2002). 
Keto esters have, however, been reported to inhibit 
anandamide hydrolase and therefore act as potent fatty acid 
amide hydrolase (FAAH) inhibitors (Malabu et al. 1992). Fatty 
acid amide hydrolase is a mammalian integral membrane 
enzyme that degrades the fatty acid amide family of 
endogenous signalling lipids, which includes the endogenous 
cannabinoid anandamide and the sleep-inducing substance 
oleamide (McKinney & Cravatt 2005). It has been reported 
that the uterus is a target for cannabinoid ligand-receptor 
signalling where it functions maybe to induce myometrial 
signalling via the adenylate cyclase pathway (Das et al. 1995; 
Dennedy et al. 2004). This therefore suggests a possible 
contribution of 3-deoxy-arabino-hept-2-ulosonic acid to the 
activity of AL in this study. Adipedatol is a triterpenoid (Ageta 
& Shiojima 1968). While there is no direct information on the 
effect of adipedatol on uterine contractility or function, there 
are studies that report the effect of triterpenoids on uterine 
contractility. Vaccaroid A, a triterpenoid from seeds of Vaccaria 
segetalis, has been reported to stimulate uterine contractility 
(Morita et al. 1997). Quassin, a triterpenoid from stem bark 
extract of Quassia amara, was also reported to exhibit reversible 
antifertility and anti-oestrogenic properties (Raji et al. 2010). 
Dalsaxin, a triterpenoid glycoside isolated from the root of 
Dalbergia saxatilis, also stimulated uterine contractility in 
rats (Uchendu & Leek 1999a, 1999b). It therefore seems that 
triterpenoids stimulate uterine contractility and adipedatol 
would not have contributed to the inhibitory effect of AL but 
may have a role to play in the mild uterine stimulation 
observed at lower concentrations on spontaneous contractions. 
The compound 17-hydroxyingenol is a terpene alcohol 
(Devappa, Makkar & Becker 2011). Terpene alcohols are 
commonly used as fragrance and flavour ingredients (Belsito 
et al. 2008); however, they are known to exert some biological 
activities as well. For instance, spathulenol, a terpene alcohol 
from Lepechinia caulescens, was reported to potently inhibit 
uterine contractility possibly via blockade of VOCCs (Perez-
Hernandez et al. 2008). In addition, 17-hydroxyingenol 
is known to inhibit phorbol 12,13-dibutyrate (PDBu) 
binding to protein kinase C (PKC) (Mbwambo et al. 1996). 
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Hydroxyingenol actively binds and activates PKC (Blanco-
Molina et al. 2001). Protein kinase C belongs to the family of 
serine or threonine kinases and is known to participate in the 
regulation of uterine smooth muscle contraction and acts 
primarily to stimulate uterine contractility (Di Liberto et al. 
2003; Kim et al. 2006; Phillippe 1994). Inhibition of PKC by 
hydroxyingenol may therefore also contribute to the effect of 
AL in this study. Phaeophorbide-a methyl ester, also detected 
in AL, has been shown to inhibit spontaneous and OT-induced 
uterine contractility (Bafor et al. 2013) and may therefore 
contribute to the effect of AL in this study.
Conclusion
The leaves of A. laxiflora have been shown in this study to 
exert inhibitory effects on uterine contractility. Its activity 
appears to occur via blockade of extracellular and intracellular 
calcium channels and may also involve regulation of K+ 
channels. The activity of A. laxiflora on uterine contractility 
has also been suggested to be a contribution of 3-deoxy-
arabino-hept-2-ulosonic acid, 17-hydroxyingenol or 
phaeophorbide-a methyl ester. These compounds may have 
acted individually or synergistically to effect the inhibitory 
activity observed. Further studies on identification of the 
metabolite directly related to the uterine inhibitory activity of 
A. laxiflora are therefore suggested. This study has provided 
data that the leaves of A. laxiflora may present as suitable 
candidates for drug development in the search for useful 
alternatives for PTL and dysmenorrhoea.
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